Cancer Outcomes Archives - Page 24 of 25

Andrew Olshan, PhD, Professor and Associate Director for Population Sciences at UNC Lineberger Comprehensive Cancer Center

A multicenter research team known as the African American Breast Cancer Epidemiology and Risk Consortium (AMBER), which includes UNC Lineberger's Andrew Olshan, PhD has uncovered differences in ER-positive & ER-negative breast cancer pathways. The team examined whether relationships between age at menarche and breast cancer are the same for tumors that are ER-positive or ER-negative, particularly among African-American women. ER-negative breast cancer is generally more aggressive and known to be associated with a poorer prognosis than ER-positive disease.

A UNC Lineberger-led report published online in JAMA Oncology describes barriers to getting patient-reported outcomes information into cancer trials and drug labels in the United States as well as recommendations for overcoming those obstacles.

Medicare recipients, private insurance patients and the uninsured all pay different prices for the same cancer treatments

The UNC Lineberger Comprehensive Cancer Center’s Director of Cancer Survivorship Deborah K. Mayer, PhD, RN, has been recognized for her commitment to the Oncology Nursing Society and to the community as a whole.

The use of robot-assisted surgery and modern radiation techniques have been rapidly adopted as treatments for prostate cancer, but a UNC Lineberger Comprehensive Cancer Center researcher is asking what the newer technologies will mean in terms of side effects and outcomes for patients in the long-term.

The American Cancer Society has honored Hyman B. Muss, MD, director of the UNC Lineberger Comprehensive Cancer Center Geriatric Oncology Program, with a prestigious national award that recognizes providers who show compassion and dedication beyond the call of duty.

UNC Lineberger's Smith was awarded a contract by the Patient-Centered Outcomes Research Institute to find the research questions that matter most to bladder cancer patients.

Compared to a control (left), mice treated with a chemotherapy drug using the device experienced significant growth reduction as confirmed by the lack of brown staining for a marker of tumor growth.

Device that drives drugs into solid tumors that are poorly vascularized opens the possibility of life-saving surgeries in cancer patients.

After comparing the survival outcomes of older and younger people with head and neck cancer, UNC Lineberger researchers have found that age alone shouldn’t dictate a patient’s treatment. The findings were published January 12 online in the journal The Oncologist.

A UNC Lineberger researcher has pointed to a need for more data on whether new technology designed to better detect men at higher-risk for prostate cancer will also mean improvements in survival rates and symptoms.

Tag: Cancer Outcomes

Early menarche may be important in development of aggressive breast cancer in African-American women

UNC Lineberger-led report details strategies for including patient-reported outcomes in cancer drug labeling

Price of cancer drugs varies widely based on who’s paying, study finds

Mayer recognized by Oncology Nursing Society

UNC Lineberger researchers to study prostate cancer treatment side effects, survival outcomes

UNC Lineberger’s Muss honored as exemplary cancer caregiver

Smith awarded funding to identify research topics that matter most to patients

Potential pancreatic cancer treatment could increase life expectancy

UNC Lineberger analysis finds that advanced age should not limit cancer treatment

Basch calls for more data on prostate cancer detection technology in JAMA editorial